Innoveren Scientific Inc.
IVRN
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 73.90K | 453.50K | 778.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 0.00 | 73.90K | 453.50K | 778.20K |
| Cost of Revenue | 1.00K | 1.00K | 31.10K | 117.60K | 267.90K |
| Gross Profit | -1.00K | -1.00K | 42.80K | 335.90K | 510.30K |
| SG&A Expenses | 2.09M | 2.28M | 2.73M | 3.39M | 3.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.09M | 2.28M | 2.76M | 3.51M | 3.65M |
| Operating Income | -2.09M | -2.28M | -2.69M | -3.06M | -2.87M |
| Income Before Tax | -3.26M | -5.04M | -8.50M | -10.30M | -9.55M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.26 | -5.04 | -8.50 | -10.30 | -9.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.26M | -5.04M | -8.50M | -10.30M | -9.55M |
| EBIT | -2.09M | -2.28M | -2.69M | -3.06M | -2.87M |
| EBITDA | -2.08M | -2.27M | -2.68M | -3.04M | -2.86M |
| EPS Basic | -6.54 | -13.85 | -27.12 | -46.75 | -47.60 |
| Normalized Basic EPS | -2.62 | -4.43 | -5.17 | -18.97 | -20.75 |
| EPS Diluted | -7.07 | -14.38 | -27.12 | -46.75 | -47.61 |
| Normalized Diluted EPS | -2.42 | -4.23 | -5.17 | -18.97 | -20.75 |
| Average Basic Shares Outstanding | 2.33M | 1.93M | 1.52M | 1.07M | 835.70K |
| Average Diluted Shares Outstanding | 2.77M | 2.37M | 1.52M | 1.07M | 835.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |